Drug Profile
Research programme: nicotinamide phosphoribosyltransferase modulators - Calico
Alternative Names: NAMPT modulators - Calico; P7C3 aminopropyl carbazloes - CalicoLatest Information Update: 28 Oct 2018
Price :
$50
*
At a glance
- Originator University of Texas Southwestern Medical Center
- Developer Calico
- Class Carbazoles
- Mechanism of Action Nicotinamide phosphoribosyltransferase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neurodegenerative disorders